Pyruvate-enhancement of post-ischemic cardiac function is not mediated by cyclic AMP

Isabel Teiero-Taldo, Jie Sun, James L. Caffrey, Robert T. Mallet

Research output: Contribution to journalArticle

Abstract

This study tested the hypothesis lhat pymvate-enhancement of post-ischemic cardiac function, like that of catecholamines, is mediated by cyclic AMP (cAMP). Isolated working guinea-pig hearts, perfused with 10 mM glucose-fortified Krebs-Henseleit, were subjected to 45 min low flow (20% of baseline) ischemia, then repcrfused for 35 min to produce reversible dysfunction (stunning). Four groups of 6 hearts were studied: 100 min nonischemic time control (TC); reperfusion without intervention (REP), or treatment with 50 nM isoproterenol OSO) or 5 mM pyruvate (PYR) at 15-35 min reperfusion. cAMP was measured in frozen myocardium by radio-immunoassay. Figure: Cardiac function (left ventricular stroke work, mj/g wet; filled bars) and cAMP content (nmol/g dry; open bars) were measured at 35 min reperfusion (P < 0.05 vs. TC. t: P < 0.05 vs. REP). In REP. cardiac function was scvcrclv imoaired. but cAMP was unchanged. As expected, ISO stimulated function and increased cAMP content. PYR also restored function to TC lclel, but did not increase cAMP content. Conclusions: Cardiac stunning is not acompanied by decreased cAMP content. PYR enhancement of post-ischemic ventricular performance is independent of cAMP. (NIH support: HL 50441).

Original languageEnglish
JournalFASEB Journal
Volume10
Issue number3
StatePublished - 1 Dec 1996

Fingerprint

Pyruvic Acid
Cyclic AMP
Reperfusion
Radio
Left Ventricular Function
Isoproterenol
Immunoassay
Catecholamines
Myocardium
Guinea Pigs
Ischemia
Stroke
Glucose

Cite this

Teiero-Taldo, Isabel ; Sun, Jie ; Caffrey, James L. ; Mallet, Robert T. / Pyruvate-enhancement of post-ischemic cardiac function is not mediated by cyclic AMP. In: FASEB Journal. 1996 ; Vol. 10, No. 3.
@article{9902107162d5488a938785705ed43012,
title = "Pyruvate-enhancement of post-ischemic cardiac function is not mediated by cyclic AMP",
abstract = "This study tested the hypothesis lhat pymvate-enhancement of post-ischemic cardiac function, like that of catecholamines, is mediated by cyclic AMP (cAMP). Isolated working guinea-pig hearts, perfused with 10 mM glucose-fortified Krebs-Henseleit, were subjected to 45 min low flow (20{\%} of baseline) ischemia, then repcrfused for 35 min to produce reversible dysfunction (stunning). Four groups of 6 hearts were studied: 100 min nonischemic time control (TC); reperfusion without intervention (REP), or treatment with 50 nM isoproterenol OSO) or 5 mM pyruvate (PYR) at 15-35 min reperfusion. cAMP was measured in frozen myocardium by radio-immunoassay. Figure: Cardiac function (left ventricular stroke work, mj/g wet; filled bars) and cAMP content (nmol/g dry; open bars) were measured at 35 min reperfusion (P < 0.05 vs. TC. t: P < 0.05 vs. REP). In REP. cardiac function was scvcrclv imoaired. but cAMP was unchanged. As expected, ISO stimulated function and increased cAMP content. PYR also restored function to TC lclel, but did not increase cAMP content. Conclusions: Cardiac stunning is not acompanied by decreased cAMP content. PYR enhancement of post-ischemic ventricular performance is independent of cAMP. (NIH support: HL 50441).",
author = "Isabel Teiero-Taldo and Jie Sun and Caffrey, {James L.} and Mallet, {Robert T.}",
year = "1996",
month = "12",
day = "1",
language = "English",
volume = "10",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "3",

}

Pyruvate-enhancement of post-ischemic cardiac function is not mediated by cyclic AMP. / Teiero-Taldo, Isabel; Sun, Jie; Caffrey, James L.; Mallet, Robert T.

In: FASEB Journal, Vol. 10, No. 3, 01.12.1996.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pyruvate-enhancement of post-ischemic cardiac function is not mediated by cyclic AMP

AU - Teiero-Taldo, Isabel

AU - Sun, Jie

AU - Caffrey, James L.

AU - Mallet, Robert T.

PY - 1996/12/1

Y1 - 1996/12/1

N2 - This study tested the hypothesis lhat pymvate-enhancement of post-ischemic cardiac function, like that of catecholamines, is mediated by cyclic AMP (cAMP). Isolated working guinea-pig hearts, perfused with 10 mM glucose-fortified Krebs-Henseleit, were subjected to 45 min low flow (20% of baseline) ischemia, then repcrfused for 35 min to produce reversible dysfunction (stunning). Four groups of 6 hearts were studied: 100 min nonischemic time control (TC); reperfusion without intervention (REP), or treatment with 50 nM isoproterenol OSO) or 5 mM pyruvate (PYR) at 15-35 min reperfusion. cAMP was measured in frozen myocardium by radio-immunoassay. Figure: Cardiac function (left ventricular stroke work, mj/g wet; filled bars) and cAMP content (nmol/g dry; open bars) were measured at 35 min reperfusion (P < 0.05 vs. TC. t: P < 0.05 vs. REP). In REP. cardiac function was scvcrclv imoaired. but cAMP was unchanged. As expected, ISO stimulated function and increased cAMP content. PYR also restored function to TC lclel, but did not increase cAMP content. Conclusions: Cardiac stunning is not acompanied by decreased cAMP content. PYR enhancement of post-ischemic ventricular performance is independent of cAMP. (NIH support: HL 50441).

AB - This study tested the hypothesis lhat pymvate-enhancement of post-ischemic cardiac function, like that of catecholamines, is mediated by cyclic AMP (cAMP). Isolated working guinea-pig hearts, perfused with 10 mM glucose-fortified Krebs-Henseleit, were subjected to 45 min low flow (20% of baseline) ischemia, then repcrfused for 35 min to produce reversible dysfunction (stunning). Four groups of 6 hearts were studied: 100 min nonischemic time control (TC); reperfusion without intervention (REP), or treatment with 50 nM isoproterenol OSO) or 5 mM pyruvate (PYR) at 15-35 min reperfusion. cAMP was measured in frozen myocardium by radio-immunoassay. Figure: Cardiac function (left ventricular stroke work, mj/g wet; filled bars) and cAMP content (nmol/g dry; open bars) were measured at 35 min reperfusion (P < 0.05 vs. TC. t: P < 0.05 vs. REP). In REP. cardiac function was scvcrclv imoaired. but cAMP was unchanged. As expected, ISO stimulated function and increased cAMP content. PYR also restored function to TC lclel, but did not increase cAMP content. Conclusions: Cardiac stunning is not acompanied by decreased cAMP content. PYR enhancement of post-ischemic ventricular performance is independent of cAMP. (NIH support: HL 50441).

UR - http://www.scopus.com/inward/record.url?scp=33749112699&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33749112699

VL - 10

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 3

ER -